Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update1d ago

MEDICO REMEDIES LIMITED

MEDICO REMEDIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Medico Remedies Limited has informed the BSE about the appointment of Cost Auditors for the financial year 2022-23.

BSECompany UpdateResults1d ago

MEDICO REMEDIES LIMITED

MEDICO REMEDIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Medico Remedies Limited has informed BSE about the appointment of Cost Auditors.

BSECompany Update1d ago

MEDICO REMEDIES LIMITED

MEDICO REMEDIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Medico Remedies Limited has informed BSE about the appointment of Cost Auditors.

BSECompany Update1d ago

MEDICO REMEDIES LIMITED

MEDICO REMEDIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Medico Remedies Limited has informed BSE about the appointment of Cost Auditors.

BSECompany UpdateAuditor Change1d ago

MEDICO REMEDIES LIMITED

MEDICO REMEDIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Medico Remedies Limited has appointed a new cost auditor, as per the Companies Act 2013.

BSECompany Update1d ago

MEDICO REMEDIES LIMITED

MEDICO REMEDIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Medico Remedies Limited has informed BSE about the appointment of Cost Auditors.

BSECompany Update1d ago

MEDICO REMEDIES LIMITED

MEDICO REMEDIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Medico Remedies Limited has informed BSE about the appointment of Cost Auditors.

BSECompany Update1d ago

MEDICO REMEDIES LIMITED

MEDICO REMEDIES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Medico Remedies Limited has informed the BSE about the appointment of Cost Auditors.

BSECompany Update▲ PositiveResults1d ago

Arvind Fashions Ltd

Arvind Fashions Limited has informed the Exchange about Transcript.

Arvind Fashions Ltd has announced its Q2 FY27 earnings conference call transcript, reporting its highest ever quarterly revenue and EBITDA. The company delivered a 10% top-line growth, aided by higher marketing investments, and a 30% PAT growth. The management remains committed to maintaining its growth trajectory through investments in tech and AI initiatives.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults1d ago

Medico Remedies Limited

Outcome of Board Meeting

Medico Remedies Limited has submitted its unaudited standalone financial results for the quarter ended September 30, 2026, along with the auditor's limited review report. The board of directors has also approved the appointment of M/s V. J. Talati & Co. as the cost auditors for the financial year ending March 31, 2027.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults1d ago

NGL Fine-Chem Limited

Copy of Newspaper Publication

NGL Fine-Chem Limited has informed the Exchange about publishing newspaper advertisements of Financial Results for the quarter and half year ended September, 30, 2026, in Free Press Journal (English) and Navshakti (Marathi) newspapers. The company is also making the information available on its website.

Read more →📎 1 attachment
NSEMonitoring Agency ReportResults1d ago

Northern Arc Capital Limited

Monitoring Agency Report

Northern Arc Capital Limited has submitted its final monitoring agency report for the quarter ended September 30, 2026, indicating that the proceeds raised through its public issue of equity shares have been fully utilized for the purposes stated in the prospectus.

Read more →📎 1 attachment
NSEAcquisitionJoint Venture1d ago

Sunteck Realty Limited

Acquisition

Sunteck Realty Limited has informed the Exchange about the incorporation of a wholly owned subsidiary, Eminara Property Private Limited.

Read more →📎 1 attachment
BSECompany UpdateInsolvency1d ago

Shish Industries Ltd

We hereby submit the Notice calling the General Meeting of Unsecured Creditors of the Company called pursuant to Order Dated October 31, 2026 issued by Hon''ble NCLT, Ahmedabad bench in the matter of Composite Scheme of Amalgamation of Shish Polylam Private Limited and Shish Global Solutions Private Limited with Shish Industries Limited

Shish Industries Ltd has announced a notice convening a general meeting of unsecured creditors to consider the proposed composite scheme of amalgamation of Shish Polylam Private Limited and Shish Global Solutions Private Limited with Shish Industries Limited, as per the directions of the Hon'ble National Company Law Tribunal, Ahmedabad Bench.

Read more →📎 1 attachment
BSEResultResults1d ago

Medico Remedies Ltd

Unaudited Standalone Financial Results for Quarter ended 30th September, 2026 along with Auditors limited review report.

Medico Remedies Ltd has announced its unaudited standalone financial results for the quarter ended 30th September 2026, along with the auditors' limited review report. The company has also appointed M/s V. J. Talati & Co. as the Cost Auditors for the financial year ending 31st March 2027. The results and appointment were approved by the Board of Directors at their meeting held on 9th November 2026.

Read more →📎 1 attachment
BSEResultResults1d ago

Whirlpool of India Ltd

As enclosed

Whirlpool of India Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with the Board of Directors approving the results and the Audit Committee reviewing the Limited Review Report of the Statutory Auditors.

Read more →📎 1 attachment
BSEBoard MeetingResults1d ago

Spice Lounge Food Works Ltd

Spice Lounge Food Works Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Un-audited Financial Results for the second quarter and half year ended on 30th Sep 2026

Spice Lounge Food Works Ltd has scheduled a board meeting on 13/11/2026 to consider and approve un-audited financial results for the second quarter and half year ended on 30th Sep 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults1d ago

Roopshri Resorts Ltd

Roopshri Resorts Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone) for Half year ended September 30, 2026 and thereon and any other business with permission of the Chairman.

Roopshri Resorts Ltd has scheduled a Board Meeting on November 13, 2026, to consider and approve the Unaudited Financial Results (Standalone) for Half year ended September 30, 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults1d ago

Umiya Tubes Ltd

Umiya Tubes Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Un-audited Limited reviewed Financial Results for the Quarter II and Half year ended on September 30, 2026

Umiya Tubes Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve Un-audited Limited reviewed Financial Results for the Quarter II and Half year ended on September 30, 2026

Read more →📎 1 attachment
← PreviousPage 87 of 14981Next →